Just one treatment with STRATA’s TheraClearX helps clear cystic and papular acne, according to a poster slated to be presented at the Maui Derm 2024 Meeting to be held at the Grand Wailea in Maui, Hawaii from January 22-26, 2024.
TheraClearX employs photopneumatic technology to deliver intense pulsed light utilizing vacuum technology with an additional needle insert; the vacuum pulls the tissue into the needle, penetrating the acne lesion and thereby creating a pathway for sebum extraction.
The majority of lesions demonstrated ≥50% clearing by 1-2 weeks after one treatment, exceeding the criteria of ≥30% reduction in lesion size at two follow-up visits, the study showed.
Moreover, the average reduction in lesion size was rated 2.0 (30-50% reduction) at 24-72 hours post-treatment and 3.5 at 1-2 weeks (≥50-75% reduction).
At 1-2 weeks, the most frequently reported event was mild hyperpigmentation; erythema, edema, and flaking were observed in ≤10% of lesions.
“We are thrilled with our results of the clinical experience study for patients suffering from moderate to severe acne,” says study author Suneel Chilukuri, MD, Director of Cosmetic Surgery at Refresh Dermatology, in a news release. “The TheraClearX Photopneumatic acne system used with the additional needle insert is a very effective and safe treatment for both cystic and pustular acne lesions. Most importantly, the procedure is extremely well tolerated by patients with all types of acne.”
